Sandra Assoun

412 total citations
8 papers, 262 citations indexed

About

Sandra Assoun is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Sandra Assoun has authored 8 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 1 paper in Infectious Diseases. Recurrent topics in Sandra Assoun's work include Lung Cancer Treatments and Mutations (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Sandra Assoun is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). Sandra Assoun collaborates with scholars based in France and Canada. Sandra Assoun's co-authors include V. Gounant, Gérard Zalcman, Solenn Brosseau, Céline Namour, Baptiste Abbar, Johan Pluvy, Aurélie Cazes, Antoine Khalil, Nathalie Théou–Anton and Claire Danel and has published in prestigious journals such as Pharmacology & Therapeutics, Intensive Care Medicine and Journal of Thoracic Oncology.

In The Last Decade

Sandra Assoun

8 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Assoun France 7 185 137 58 54 35 8 262
Mihai Vasile Marinca Romania 8 136 0.7× 66 0.5× 57 1.0× 57 1.1× 12 0.3× 31 253
Pierre Van Mol Belgium 5 107 0.6× 98 0.7× 27 0.5× 65 1.2× 52 1.5× 10 239
Claire Tissot France 10 208 1.1× 261 1.9× 134 2.3× 107 2.0× 15 0.4× 22 394
Omar Abdihamid United States 8 79 0.4× 81 0.6× 45 0.8× 74 1.4× 11 0.3× 27 197
Theresa Westphal Austria 8 168 0.9× 53 0.4× 65 1.1× 52 1.0× 15 0.4× 14 246
Gemma Caliendo Italy 10 84 0.5× 69 0.5× 86 1.5× 119 2.2× 19 0.5× 17 291
Nathalie Vaissière France 8 195 1.1× 163 1.2× 43 0.7× 22 0.4× 16 0.5× 19 293
Roxana Reyes Spain 9 211 1.1× 161 1.2× 40 0.7× 64 1.2× 7 0.2× 22 307
Yonglin Cai China 10 149 0.8× 46 0.3× 93 1.6× 99 1.8× 9 0.3× 30 300
Yuequan Shi China 10 170 0.9× 89 0.6× 24 0.4× 43 0.8× 17 0.5× 27 265

Countries citing papers authored by Sandra Assoun

Since Specialization
Citations

This map shows the geographic impact of Sandra Assoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Assoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Assoun more than expected).

Fields of papers citing papers by Sandra Assoun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Assoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Assoun. The network helps show where Sandra Assoun may publish in the future.

Co-authorship network of co-authors of Sandra Assoun

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Assoun. A scholar is included among the top collaborators of Sandra Assoun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Assoun. Sandra Assoun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Delaye, Matthieu, et al.. (2023). Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?. Pharmacology & Therapeutics. 247. 108442–108442. 7 indexed citations
2.
Gounant, V., Valentine Marie Ferré, Charlotte Charpentier, et al.. (2021). Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses. Journal of Thoracic Oncology. 17(2). 239–251. 36 indexed citations
3.
Abbar, Baptiste, Paul Gougis, Sandra Assoun, et al.. (2020). Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors. Lung Cancer. 152. 109–118. 12 indexed citations
4.
Assoun, Sandra, Nathalie Théou–Anton, Aurélie Cazes, et al.. (2019). Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer. Lung Cancer. 132. 65–71. 117 indexed citations
5.
Seferian, Andrei, Xavier Jaïs, Mitja Jevnikar, et al.. (2019). Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertension. Respiratory Medicine and Research. 76. 48–53. 5 indexed citations
6.
Assoun, Sandra, Virginie Lemiale, & Élie Azoulay. (2019). Molecular targeted therapy-related life-threatening toxicity in patients with malignancies. A systematic review of published cases. Intensive Care Medicine. 45(7). 988–997. 19 indexed citations
7.
Brosseau, Solenn, et al.. (2017). A review of bevacizumab in the treatment of malignant pleural mesothelioma. Future Oncology. 13(28). 2537–2546. 15 indexed citations
8.
Assoun, Sandra, et al.. (2017). Bevacizumab in advanced lung cancer: state of the art. Future Oncology. 13(28). 2515–2535. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026